Return On Equity of Calidi Biotherapeutics, Inc. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Calidi Biotherapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • Calidi Biotherapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -432%, a 282% decline year-over-year.
  • Calidi Biotherapeutics, Inc. annual Return On Equity for 2024 was 259%, a 184% increase from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Calidi Biotherapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -432% -669% -282% 01 Jul 2025 30 Sep 2025
Q2 2025 -5159% -5420% -2078% 01 Apr 2025 30 Jun 2025
Q1 2025 651% +514% +375% 01 Jan 2025 31 Mar 2025
Q4 2024 259% +168% +184% 01 Oct 2024 31 Dec 2024
Q3 2024 237% +169% +251% 01 Jul 2024 30 Sep 2024
Q2 2024 261% 01 Apr 2024 30 Jun 2024
Q1 2024 137% 01 Jan 2024 31 Mar 2024
Q4 2023 91% 01 Oct 2023 31 Dec 2023
Q3 2023 68% 01 Jul 2023 30 Sep 2023

Calidi Biotherapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 259% +168% +184% 01 Jan 2024 31 Dec 2024
2023 91% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.